BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 26536778)

  • 21. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
    Saegusa J; Kawano S; Morinobu A
    Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
    Zhao YY; Lin RC
    Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics in Systems Biology.
    Baharum SN; Azizan KA
    Adv Exp Med Biol; 2018; 1102():51-68. PubMed ID: 30382568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology.
    Aretz I; Meierhofer D
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Qi Y; Song Y; Gu H; Fan G; Chai Y
    Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capillary electrophoresis-mass spectrometry using a flow-through microvial interface for cationic metabolome analysis.
    Lindenburg PW; Ramautar R; Jayo RG; Chen DD; Hankemeier T
    Electrophoresis; 2014 May; 35(9):1308-14. PubMed ID: 24375112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic profiling of plant tissues.
    Rambla JL; López-Gresa MP; Bellés JM; Granell A
    Methods Mol Biol; 2015; 1284():221-35. PubMed ID: 25757775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "OMICS" technologies and their role in foregut primary malignancies.
    Farid SG; Morris-Stiff G
    Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
    [No Abstract]   [Full Text] [Related]  

  • 30. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
    Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
    Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J; Datla R; Chan S; Borchers CH
    Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism.
    Büscher JM; Czernik D; Ewald JC; Sauer U; Zamboni N
    Anal Chem; 2009 Mar; 81(6):2135-43. PubMed ID: 19236023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TagFinder: preprocessing software for the fingerprinting and the profiling of gas chromatography-mass spectrometry based metabolome analyses.
    Luedemann A; von Malotky L; Erban A; Kopka J
    Methods Mol Biol; 2012; 860():255-86. PubMed ID: 22351182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics, peptidomics and proteomics applications of capillary electrophoresis-mass spectrometry in Foodomics: a review.
    Ibáñez C; Simó C; García-Cañas V; Cifuentes A; Castro-Puyana M
    Anal Chim Acta; 2013 Nov; 802():1-13. PubMed ID: 24176500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.
    García A; Godzien J; López-Gonzálvez Á; Barbas C
    Bioanalysis; 2017 Jan; 9(1):99-130. PubMed ID: 27921456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fourier transform mass spectrometry for metabolome analysis.
    Junot C; Madalinski G; Tabet JC; Ezan E
    Analyst; 2010 Sep; 135(9):2203-19. PubMed ID: 20574587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
    Buck A; Aichler M; Huber K; Walch A
    Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
    Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
    Ni Y; Xie G; Jia W
    J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.